Compare TAP & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAP | RVTY |
|---|---|---|
| Founded | 1873 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.8B |
| IPO Year | N/A | 1994 |
| Metric | TAP | RVTY |
|---|---|---|
| Price | $42.60 | $87.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 15 |
| Target Price | $50.31 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 2.9M | 1.0M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | ★ 4.53% | 0.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $0.85 | $6.34 |
| Revenue Next Year | $0.14 | $5.10 |
| P/E Ratio | ★ N/A | $42.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $42.08 | $81.36 |
| 52 Week High | $63.40 | $118.30 |
| Indicator | TAP | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 28.89 | 35.08 |
| Support Level | N/A | $82.98 |
| Resistance Level | $47.36 | $88.60 |
| Average True Range (ATR) | 1.10 | 3.11 |
| MACD | -0.61 | -0.69 |
| Stochastic Oscillator | 7.09 | 26.55 |
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.